Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study
<h4>Background</h4> The objective of this study was to estimate the economic burden attributable to laboratory-confirmed Lyme disease (LD) in Ontario, Canada and assess health outcomes associated with LD. <h4>Method</h4> We conducted a cohort study using laboratory-confirmed...
Main Authors: | Stephen Mac, Gerald Evans, Eleanor Pullenayegum, Samir N. Patel, Beate Sander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286989/?tool=EBI |
Similar Items
-
Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study.
by: Stephen Mac, et al.
Published: (2023-01-01) -
Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014.
by: Karen O Johnson, et al.
Published: (2018-01-01) -
The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.
by: Stephen Mac, et al.
Published: (2019-01-01) -
Spatiotemporal trends and socioecological factors associated with Lyme disease in eastern Ontario, Canada from 2010–2017
by: Andreea M. Slatculescu, et al.
Published: (2022-04-01) -
The direct healthcare costs attributable to West Nile virus illness in Ontario, Canada: a population-based cohort study using laboratory and health administrative data
by: Emily Shing, et al.
Published: (2019-12-01)